Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Bank of America €1.5 billion fixed/floating-rate senior notes offering
We advised the joint-lead managers on the offering pursuant to the issuer’s euro medium-term note program
Anglo American $1 billion notes offering
We advised the underwriters on the Rule 144A senior notes offering
European Biotech Acquisition $120 million IPO
We advised European Biotech Acquisition, a SPAC, on its IPO and Nasdaq listing
Sasol $1.5 billion notes offering
We advised the underwriters on the SEC-registered offering
Macy’s $500 million senior notes offering, tender offer and consent solicitation
We advised the initial purchasers on the high-yield notes offering, concurrent tender offer and related consent solicitation
Oncopeptides SEK 1.1 billion private placing of new shares
We advised Oncopeptides on the private placement of shares
Manchester United offering of Class A ordinary shares
We advised the underwriter on the secondary offering
Bandwidth $250 million convertible senior notes offering
We advised the initial purchasers on the Rule 144A convertible notes offering
eToro Group $650 million PIPE investment
We advised the placement agents on the private placement
Prometheus Biosciences $218.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing